Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group.

MLA

Rovira, Àlex, et al. “Use of Gadolinium-Based Contrast Agents in Multiple Sclerosis: A Review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group.” European Radiology, vol. 34, no. 3, Mar. 2024, pp. 1726–35. EBSCOhost, https://doi.org/10.1007/s00330-023-10151-y.

APA

Rovira, À., Doniselli, F. M., Auger, C., Haider, L., Hodel, J., Severino, M., Wattjes, M. P., van der Molen, A. J., Jasperse, B., Mallio, C. A., Yousry, T., & Quattrocchi, C. C. (2024). Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group. European Radiology, 34(3), 1726–1735. https://doi.org/10.1007/s00330-023-10151-y

Chicago

Rovira, Àlex, Fabio M. Doniselli, Cristina Auger, Lukas Haider, Jerome Hodel, Mariasavina Severino, Mike P. Wattjes, et al. 2024. “Use of Gadolinium-Based Contrast Agents in Multiple Sclerosis: A Review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group.” European Radiology 34 (3): 1726–35. doi:10.1007/s00330-023-10151-y.